Edgar Filing: HOFFMAN GABE

Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Expires:

January 31, 2005

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

ACCIPITER CAPITAL MANAGEMENT, LLC

2. Issuer Name and Ticker or Trading Symbol
Emergency Medical Services CORP [EMS]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	__X__ 10% Owner
_____ Officer (give title below)	_____ Other (specify below)

(Last)

(First)

(Middle)

399 PARK AVENUE, 38TH FLOOR

3. Date of Earliest Transaction (Month/Day/Year)
01/03/2006

(Street)

NEW YORK, NY 10022

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
___ Form filed by One Reporting Person
_X_ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Class A Common Stock	01/03/2006		J⁽¹⁾		70,979	D	$ 13.4	307,513	I	By ALSF (Offshore), Ltd. ⁽²⁾
Class A Common Stock	01/06/2006		P		7,078	A	$ 12.9	314,591	I	By ALSF (Offshore), Ltd. ⁽²⁾
Class A Common Stock	01/23/2006		J⁽³⁾		13,569	D	$ 12.87	301,022	I	By ALSF (Offshore), Ltd. ⁽²⁾
Class A Common Stock	01/03/2006		J⁽¹⁾		103,080	A	$ 13.4	103,080	I	By ALSF II (Offshore), Ltd. ⁽⁴⁾
Class A Common Stock	01/06/2006		P		6,271	A	$ 12.9	109,351	I	By ALSF II (Offshore), Ltd. ⁽⁴⁾
Class A Common Stock	01/18/2006		P		3,912	A	$ 13	113,263	I	By ALSF II (Offshore), Ltd. ⁽⁴⁾
Class A Common Stock	01/19/2006		P		17,110	A	$ 12.9324	130,373	I	By ALSF II (Offshore), Ltd. ⁽⁴⁾
Class A Common Stock	01/23/2006		J⁽³⁾		8,570	D	$ 12.87	121,803	I	By ALSF II (Offshore), Ltd. ⁽⁴⁾
Class A Common Stock	01/03/2006		J		63,435	A	$ 13.4	63,435	I	By ALSF II (QP), LP ⁽⁵⁾
Class A Common Stock	01/06/2006		P		3,760	A	$ 12.9	67,195	I	By ALSF II (QP), LP ⁽⁵⁾
Class A Common Stock	01/18/2006		P		2,393	A	$ 13	69,588	I	By ALSF II (QP), LP ⁽⁵⁾
Class A Common Stock	01/19/2006		P		10,510	A	$ 12.9324	80,098	I	By ALSF II (QP), LP ⁽⁵⁾
Class A Common Stock	01/23/2006		J⁽³⁾		16,930	D	$ 12.87	63,168	I	By ALSF II (QP), LP ⁽⁵⁾
Class A Common Stock	01/03/2006		J⁽¹⁾		30,235	A	$ 13.4	98,885	I	By ALSF II, LP ⁽⁶⁾
Class A Common Stock	01/06/2006		P		5,863	A	$ 12.9	104,748	I	By ALSF II, LP ⁽⁶⁾
Class A Common Stock	01/18/2006		P		3,695	A	$ 13	108,443	I	By ALSF II, LP ⁽⁶⁾
Class A Common Stock	01/19/2006		P		16,380	A	$ 12.9324	124,823	I	By ALSF II, LP ⁽⁶⁾
Class A Common Stock	01/23/2006		J⁽³⁾		69,748	A	$ 12.87	194,571	I	By ALSF II, LP ⁽⁶⁾
Class A Common Stock	01/03/2006		J⁽¹⁾		125,771	D	$ 13.4	360,387	I	By ALSF, LP ⁽⁷⁾
Class A Common Stock	01/06/2006		P		7,028	A	$ 12.9	367,415	I	By ALSF, LP ⁽⁷⁾
Class A Common Stock	01/23/2006		J⁽³⁾		30,679	D	$ 12.87	336,736	I	By ALSF, LP ⁽⁷⁾

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
ACCIPITER CAPITAL MANAGEMENT, LLC 399 PARK AVENUE 38TH FLOOR NEW YORK, NY 10022		X
HOFFMAN GABE 399 PARK AVENUE 38TH FLOOR NEW YORK, NY 10022		X
Candens Capital LLC 399 PARK AVENUE 38TH FLOOR NEW YORK, NY		X

Signatures

By: /s/ Gabe Hoffman, managing member		02/06/2006
^**Signature of Reporting Person		Date
/s/ Hoffman, Gabe		02/06/2006
^**Signature of Reporting Person		Date
By: /s/ Gabe Hoffman, managing member		02/06/2006
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	On January 3, 2006, Accipiter Life Sciences Fund, LP and Accipiter Life Sciences Fund (Offshore), Ltd. transferred shares to Accipiter Life Sciences Fund II, LP, Accipiter Life Sciences Fund II (Offshore), Ltd. and Accipiter Life Sciences Fund II (QP), LP. The prices disclosed in the table above reflect the closing price of the Issuer's Class A Common Stock on the date thereof.
(2)	Held by Accipiter Life Sciences Fund (Offshore), Ltd. Accipiter Capital Management, LLC, the investment manager of Accipiter Life Sciences Fund (Offshore), Ltd. and Gabe Hoffman, the managing member of Accipiter Capital Management, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
(3)	On January 23, 2006, Accipiter Life Sciences Fund, LP, Accipiter Life Sciences Fund (Offshore), Ltd., Accipiter Life Sciences Fund II (Offshore), Ltd. and Accipiter Life Sciences Fund II (QP), LP transferred shares to Accipiter Life Sciences Fund II, LP. The prices disclosed in the table above reflect the closing price of the Issuer's Class A Common Stock on the date thereof.
(4)	Held by Accipter Life Scieces Fund II (Offshore), Ltd. Accipiter Capital Management, LLC, the investment manager of Accipter Life Scieces Fund II (Offshore), Ltd. and Gabe Hoffman, the managing member of Accipiter Capital Managment, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
(5)	Held by Accipter Life Scieces Fund II (QP), LP. Candens Capital, LLC, the general partner of Accipter Life Scieces Fund II (QP), LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
(6)	Held by Accipiter Life Sciences Fund II, LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund II, LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therein.
(7)	Held by Accipiter Life Sciences Fund, LP. Candens Capital, LLC, the general partner of Accipiter Life Sciences Fund, LP and Gabe Hoffman, the managing member of Candens Capital, LLC, disclaim beneficial ownership of these securities except to the extent of their pecuniary interest therin.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.